Biochemical and Pharmacological Analysis of 2-((2-Dimethylaminobenzyl)sulfinyl)benzimidazole (NC-1300), a New Proton Pump Inhibitor.

The Japanese Journal of Pharmacology
doi 10.1254/jjp.40.239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Metabolic Fate of (.+-.)-2-((2-(Isobutylmethylamino)benzyl)sulfinyl)-1h-Benzimidazole (NC-1300-O-3). (3): Metabolism in Rats and Dogs.

Drug Metabolism and Pharmacokinetics
1994English

(R)-(+)-2-{[(3-Methyl-4-Nitropyridin-2-Yl)methyl]sulfinyl}-1h-Benzimidazole

Acta Crystallographica Section E Structure Reports Online
2011English

Biochemical and Pharmacological Properties of a Newly Synthesized Proton Pump (H+/K+-ATPase) Inhibitor, TY-11345 in Experimental Animals.

The Japanese Journal of Pharmacology
1993English

Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency

Gastroenterology
HepatologyGastroenterology
2017English

Exam 2: Association Between Proton Pump Inhibitor Use and Cognitive Function in Women

Gastroenterology
HepatologyGastroenterology
2017English

Hypomagnesemia Associated With a Proton Pump Inhibitor

Internal Medicine
Internal MedicineMedicine
2012English

Letter: Proton Pump Inhibitor Use and Risk of Fracture

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Eosinophilic Esophagitis Versus Proton Pump Inhibitor–responsive Esophageal Eosinophilia: Transcriptome Analysis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Proton Pump Inhibitor-Amoxicillin-Clarithromycin Versus Proton Pump Inhibitor-Amoxicillin-Metronidazole as First-Line Helicobacter Pylori Eradication Therapy

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy